• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

real-world data (RWD)

Veradigm Invests $30M in Behavioral Health Co. Holmusk

by Fred Pennic 10/03/2023 Leave a Comment

Veradigm Invests $30M in Behavioral Health Co. Holmusk

What You Should Know:  - Veradigm Inc. (NASDAQ: MDRX), a  provider of healthcare data and technology solutions, announced it has made a $30M strategic investment in Holmusk, a global behavioral  health real-world evidence company. The strategic investment builds on the strengths of each company to fuel innovation in behavioral health and create the evidence needed to move the field forward.  - In this new phase of the collaboration, cohorts of millions of behavioral
Read More

Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD

by Syed Hamza Sohail 09/27/2023 Leave a Comment

Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD

What You Should Know: Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis.Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate
Read More

COTA Launches EHR Dataset to Advance Generative AI Models for Cancer Care

by Jasmine Pennic 09/26/2023 Leave a Comment

COTA Launches EHR Dataset to Advance Generative AI Models for Cancer Care

What You Should Know: - COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer care. - Vista will provide biopharmaceutical companies with timely insights from real-world data sources to bring life-saving therapies to market faster. Vista uses automated data abstraction techniques, machine learning algorithms, and medical expert
Read More

Atropos Health Goes Global With New Funding from Samsung, Presido Ventures

by Syed Hamza Sohail 09/21/2023 Leave a Comment

Atropos Health Goes Global With New Funding from Samsung, Presido Ventures

What You Should Know: Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced that it has completed strategic financing from Presidio Ventures, the venture arm of Sumitomo Corporation, Samsung Next, a venture arm of Samsung Electronics, Gaingels, and others.The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S., using its proprietary technology and approach. The
Read More

OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience

by Jasmine Pennic 09/07/2023 Leave a Comment

OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience

What You Should Know: Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months. Parkinson’s Disease Premium Dataset Nearly
Read More

FDA Taps Flatiron for 5-Year Real-World Data Collaboration

by Syed Hamza Sohail 09/06/2023 Leave a Comment

FDA Taps Flatiron for 5-Year Real-World Data Collaboration

What You Should Know: Flatiron Health today announced its renewed collaboration with the Oncology Center of Excellence (OCE) of FDA to jointly develop and implement specific research projects to advance the use of Real World Data (RWD) and explore the potential strengths and limitations of using Real World Evidence (RWE) for regulatory purposes.The partnership will specifically evaluate RWD study designs and analytic methods through the collaborative development of priority, clinically
Read More

PicnicHealth Enters Oncology Real-World Data Market

by Syed Hamza Sohail 08/23/2023 Leave a Comment

PicnicHealth Enters Oncology Real-World Data Market

What You Should Know: PicnicHealth, a patient-centered health technology company, today announced its entry into the real-world data market for oncology.Drawing from its success working with chronic disease patients to create robust datasets, the company aims to advance oncology research using a similar model by working directly with people living with cancer to collect and structure their medical records data. PicnicHealth is actively exploring partnerships to develop new patient
Read More

Surgo Health Launches RWD-Driven Socio-Behavioral Analytics Platform

by Jasmine Pennic 03/03/2023 Leave a Comment

Surgo Health Launches RWD-Driven Socio-Behavioral Analytics Platform

What You Should Know: - Surgo Health, a new healthcare technology company dedicated to personalized care announced its official launch in Washington, D.C. - Formed as a public benefits company (PBC), Surgo Health is building on the analytics and proprietary data assets from Surgo Ventures and is developing a revolutionary socio-behavioral analytics platform and generating novel, real-world data to enable a greater understanding of the complex factors that influence how individuals engage
Read More

Ontada, Merck Partner to Facilitate Real World Evidence Studies for Cancer Care

by Jasmine Pennic 08/27/2021 Leave a Comment

Ontada, Merck Partner to Facilitate Real World Evidence Studies for Cancer Care

What You Should Know: - Ontada, McKesson’s oncology and insights business, announced a strategic agreement with Merck, known as MSD outside the United States and Canada, that will facilitate the development of real-world research excellence and innovation. This agreement enables the two healthcare leaders to harness the power of real-world evidence (RWE) towards the common goal of improving patient outcomes and the quality of cancer care. - Ontada and Merck’s combined experience and
Read More

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

by Fred Pennic 11/18/2020 Leave a Comment

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

What You Should Know: - COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding. - Access to over one million patient data records and additional funding support enhanced real-world data and analytics services in oncology. COTA, Inc., a Boston, MA-based healthcare technology company that uses real-world data to bring clarity to cancer care, today announced it has raised $34 million in Series D funding led by
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |